Rob van Hest

683 total citations
19 papers, 360 citations indexed

About

Rob van Hest is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Rob van Hest has authored 19 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 16 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Rob van Hest's work include Tuberculosis Research and Epidemiology (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (6 papers). Rob van Hest is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (6 papers). Rob van Hest collaborates with scholars based in Netherlands, United Kingdom and Romania. Rob van Hest's co-authors include Gèrard de Vries, Ibrahim Abubakar, Hubert F. Baars, Nico Kalisvaart, Sytze Keizer, Sandra V. Kik, Martien W. Borgdorff, M. Mensen, Frank Cobelens and D Antoine and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Rob van Hest

19 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob van Hest Netherlands 12 237 204 84 41 21 19 360
Ulrik Bak Dragsted Denmark 11 312 1.3× 145 0.7× 36 0.4× 9 0.2× 11 0.5× 18 406
Guadalupe Delgado-Sánchez Mexico 14 468 2.0× 445 2.2× 258 3.1× 12 0.3× 16 0.8× 38 675
Snider De United States 7 365 1.5× 266 1.3× 190 2.3× 133 3.2× 7 0.3× 12 541
Sriprapa Nateniyom Thailand 13 446 1.9× 375 1.8× 189 2.3× 14 0.3× 7 0.3× 24 539
Muayad Aghali Merza Iraq 12 385 1.6× 252 1.2× 163 1.9× 5 0.1× 13 0.6× 39 523
Alexander Pasechnikov United States 8 700 3.0× 557 2.7× 292 3.5× 20 0.5× 5 0.2× 9 762
M. Mensen Netherlands 8 331 1.4× 261 1.3× 189 2.3× 40 1.0× 4 0.2× 10 444
Stephanie Ngai United States 8 83 0.4× 103 0.5× 27 0.3× 23 0.6× 9 0.4× 16 259
Robert Bwire Netherlands 13 213 0.9× 144 0.7× 129 1.5× 6 0.1× 17 0.8× 24 376
Desalegn Admassu Ayana Ethiopia 12 73 0.3× 104 0.5× 44 0.5× 10 0.2× 5 0.2× 25 412

Countries citing papers authored by Rob van Hest

Since Specialization
Citations

This map shows the geographic impact of Rob van Hest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob van Hest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob van Hest more than expected).

Fields of papers citing papers by Rob van Hest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob van Hest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob van Hest. The network helps show where Rob van Hest may publish in the future.

Co-authorship network of co-authors of Rob van Hest

This figure shows the co-authorship network connecting the top 25 collaborators of Rob van Hest. A scholar is included among the top collaborators of Rob van Hest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob van Hest. Rob van Hest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vries, Gèrard de, Onno W. Akkerman, Martin J. Boeree, et al.. (2023). Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010–2019. The International Journal of Tuberculosis and Lung Disease. 27(6). 471–477. 2 indexed citations
2.
Hest, Rob van, Ibrahim Abubakar, Alistair Story, et al.. (2022). Tuberculosis Surveillance in Romania Among Vulnerable Risk Groups Between 2015 and 2017. Therapeutics and Clinical Risk Management. Volume 18. 439–446. 21 indexed citations
4.
Hest, Rob van, et al.. (2021). Travel history and challenges of screening for latent TB infection in child asylum seekers. The International Journal of Tuberculosis and Lung Disease. 25(11). 945–947. 1 indexed citations
5.
Carvalho, Carlos, Sandra Alba, Ross Harris, et al.. (2020). Completeness of TB notification in Portugal, 2015: an inventory and capture-recapture study. The International Journal of Tuberculosis and Lung Disease. 24(11). 1186–1193. 1 indexed citations
6.
Straetemans, Masja, Mirjam I. Bakker, Sandra Alba, et al.. (2020). Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016. Eurosurveillance. 25(12). 14 indexed citations
8.
Gupta, Rishi K, Marc Lipman, Alistair Story, et al.. (2018). Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era. The International Journal of Tuberculosis and Lung Disease. 22(5). 479–487. 18 indexed citations
9.
Vries, Gèrard de, Rob van Hest, Marleen Bakker, et al.. (2017). Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 7. 40–48. 14 indexed citations
10.
Lokate, Mariëtte, Alewijn Ott, Alex W. Friedrich, et al.. (2016). High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015. PLoS ONE. 11(5). e0154791–e0154791. 32 indexed citations
11.
Zenner, Dominik, Jo Southern, Rob van Hest, et al.. (2013). Active case finding for tuberculosis among high-risk groups in low-incidence countries [State of the art series. Case finding/screening. Number 3 in the series]. The International Journal of Tuberculosis and Lung Disease. 17(5). 573–582. 54 indexed citations
12.
Hest, Rob van, Csaba Ködmön, Suzanne Verver, et al.. (2012). Tuberculosis treatment outcome monitoring in European Union countries: systematic review. European Respiratory Journal. 41(3). 635–643. 26 indexed citations
13.
Hest, Rob van, Andrew Grant, & Ibrahim Abubakar. (2011). Quality assessment of capture–recapture studies in resource‐limited countries. Tropical Medicine & International Health. 16(8). 1019–1041. 8 indexed citations
14.
Hartwig, Nico G., Adilia Warris, Esther van de Vosse, et al.. (2011). “Mycobacterium tilburgii” Infection in Two Immunocompromised Children: Importance of Molecular Tools in Culture-Negative Mycobacterial Disease Diagnosis. Journal of Clinical Microbiology. 49(12). 4409–4411. 13 indexed citations
15.
Dunbar, Rory, Rob van Hest, Kitty Lawrence, et al.. (2011). Capture-recapture to estimate completeness of tuberculosis surveillance in two communities in South Africa. The International Journal of Tuberculosis and Lung Disease. 15(8). 1038–1043. 23 indexed citations
16.
Hest, Rob van & Alistair Story. (2009). [Tuberculosis control in homeless persons in European Union: more than words alone].. PubMed. 58(2). 84–7. 3 indexed citations
17.
Hest, Rob van, Hubert F. Baars, Sandra V. Kik, et al.. (2004). Hepatotoxicity of Rifampin-Pyrazinamide and Isoniazid Preventive Therapy and Tuberculosis Treatment. Clinical Infectious Diseases. 39(4). 488–496. 92 indexed citations
18.
Hest, Rob van, et al.. (2004). Cavitating Tuberculosis in an Infant. The Pediatric Infectious Disease Journal. 23(7). 667–670. 8 indexed citations
19.
Hest, Rob van, Martin J. Boeree, Kristin Kremer, et al.. (2004). Mycobacterium heckeshornense Infection in an Immunocompetent Patient and Identification by 16S rRNA Sequence Analysis of Culture Material and a Histopathology Tissue Specimen. Journal of Clinical Microbiology. 42(9). 4386–4389. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026